Job Summary. The Patient Services Representative, Collections Lead will be responsible for leading, supporting, and training for the timely and accurate collections of account receivables for all insurances and third-party billers along with partnering with the prior authorization and billing departments to maximize company revenue. General Accountabilities. Help train new hires on process and procedures within the department. Maintain training t...
Advanced Oxygen Therapy, Inc. (AOTI) provides innovative solutions to help resolve chronic non-healing and acute complex wounds. We operate on the core values of Innovation, Scientific Leadership, Health Equity, People First, and Integrity. AOTI is recognized as a leader in wound care technology around the world. With a leading international management team, an extensive worldwide infrastructure, innovative, patented technology, and an extensive ...
AOTI is the global leader in multimodality topical wound oxygen therapy. Our patented non-invasive Topical Wound Oxygen (TWO2) therapy is the only device that has demonstrated in Randomized Controlled Trial (RCT) and Real-World Evidence (RWE) studies to heal Diabetic Foot Ulcers (DFUs), resulting in an unprecedented 88 percent reduction in hospitalizations and 71 percent reduction in amputations over 12 months – because of this and more, AOTI is ...
AOTI is the global leader in multimodality topical wound oxygen therapy. Our patented non-invasive Topical Wound Oxygen (TWO2) therapy is the only device that has demonstrated in Randomized Controlled Trial (RCT) and Real-World Evidence (RWE) studies to heal Diabetic Foot Ulcers (DFUs), resulting in an unprecedented 88 percent reduction in hospitalizations and 71 percent reduction in amputations over 12 months – because of this and more, AOTI is ...
AOTI is the global leader in multimodality topical wound oxygen therapy. Our patented non-invasive Topical Wound Oxygen (TWO2) therapy is the only device that has demonstrated in Randomized Controlled Trial (RCT) and Real-World Evidence (RWE) studies to heal Diabetic Foot Ulcers (DFUs), resulting in an unprecedented 88 percent reduction in hospitalizations and 71 percent reduction in amputations over 12 months – because of this and more, AOTI is ...
AOTI is the global leader in multimodality topical wound oxygen therapy. Our patented non-invasive Topical Wound Oxygen (TWO2) therapy is the only device that has demonstrated in Randomized Controlled Trial (RCT) and Real-World Evidence (RWE) studies to heal Diabetic Foot Ulcers (DFUs), resulting in an unprecedented 88 percent reduction in hospitalizations and 71 percent reduction in amputations over 12 months – because of this and more, AOTI is ...
AOTI is the global leader in multimodality topical wound oxygen therapy. Our patented non-invasive Topical Wound Oxygen (TWO2) therapy is the only device that has demonstrated in Randomized Controlled Trial (RCT) and Real-World Evidence (RWE) studies to heal Diabetic Foot Ulcers (DFUs), resulting in an unprecedented 88 percent reduction in hospitalizations and 71 percent reduction in amputations over 12 months – because of this and more, AOTI is ...
AOTI is the global leader in multimodality topical wound oxygen therapy. Our patented non-invasive Topical Wound Oxygen (TWO2) therapy is the only device that has demonstrated in Randomized Controlled Trial (RCT) and Real-World Evidence (RWE) studies to heal Diabetic Foot Ulcers (DFUs), resulting in an unprecedented 88 percent reduction in hospitalizations and 71 percent reduction in amputations over 12 months – because of this and more, AOTI is ...
AOTI is the global leader in multimodality topical wound oxygen therapy. Our patented non-invasive Topical Wound Oxygen (TWO2) therapy is the only device that has demonstrated in Randomized Controlled Trial (RCT) and Real-World Evidence (RWE) studies to heal Diabetic Foot Ulcers (DFUs), resulting in an unprecedented 88 percent reduction in hospitalizations and 71 percent reduction in amputations over 12 months – because of this and more, AOTI is ...
AOTI is the global leader in multimodality topical wound oxygen therapy. Our patented non-invasive Topical Wound Oxygen (TWO2) therapy is the only device that has demonstrated in Randomized Controlled Trial (RCT) and Real-World Evidence (RWE) studies to heal Diabetic Foot Ulcers (DFUs), resulting in an unprecedented 88 percent reduction in hospitalizations and 71 percent reduction in amputations over 12 months – because of this and more, AOTI is ...
AOTI is the global leader in multimodality topical wound oxygen therapy. Our patented non-invasive Topical Wound Oxygen (TWO2) therapy is the only device that has demonstrated in Randomized Controlled Trial (RCT) and Real-World Evidence (RWE) studies to heal Diabetic Foot Ulcers (DFUs), resulting in an unprecedented 88 percent reduction in hospitalizations and 71 percent reduction in amputations over 12 months – because of this and more, AOTI is ...
AOTI is the global leader in multimodality topical wound oxygen therapy. Our patented non-invasive Topical Wound Oxygen (TWO2) therapy is the only device that has demonstrated in Randomized Controlled Trial (RCT) and Real-World Evidence (RWE) studies to heal Diabetic Foot Ulcers (DFUs), resulting in an unprecedented 88 percent reduction in hospitalizations and 71 percent reduction in amputations over 12 months – because of this and more, AOTI is ...
